• Development and evaluation of improved substance use disorder treatments such as inhibition training for patients with alcohol use disorders or integrated treatment programs for comorbid psychiatric disorders
  • Epidemiology, diagnosis, and treatment of attention deficit/hyperactivity disorders (ADHD) in representative samples or in patients with substance use disorders
  • Understanding of mechanisms of craving, neurophysiological cue-reactivity, and relapse in patients with alcohol use isorders
  • Predictors of successful treatment courses and in patients with substance use disorders or patients with psychiatric comorbidity.



  • Clinical questionnaires and interviews for substance use, psychiatric symptoms, and social functioning.
  • Neurophysiological methods such as fMRI and EEG and endocrinological methods such as assessment of cortisol.
  • Testing the reliability, validity and applicability of clinical assessments.
  • Experimental and observational, cross-sectional and longitudinal, single- and multi-site, and international and international studies